These data complement our previous observation that TSLP induction mounts a robust Th2 cell response preventing breast tumor development by inducing terminal differentiation of the early-stage breast cancer cells (Demehri et al., 2016; Boieri et al., 2022). The gene discussed is TSLP; the disease is breast carcinoma.